Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Largecap Value Opp Alphadex First Trust | FTA | Nov 22, 2024 | 82.72 | +0.91 |
Largo | LGO | Nov 22, 2024 | 2.02 | -0.74 |
Larimar Therapeutics | LRMR | Nov 22, 2024 | 6.16 | +0.49 |
Las Vegas Sands | LVS | Nov 22, 2024 | 50.08 | +0.02 |
Laser Photonics | LASE | Nov 22, 2024 | 6.55 | +8.26 |
Latham Group | SWIM | Nov 22, 2024 | 6.89 | +9.02 |
Latin America Alphadex First Trust | FLN | Nov 22, 2024 | 16.69 | +0.72 |
Lattice Semiconductor | LSCC | Nov 22, 2024 | 54.21 | +3.73 |
Launch One Acquisition | LPAAU | Nov 22, 2024 | 10.05 | +0.05 |
Launch One Acquisition | LPAA | Nov 22, 2024 | 10.01 | 0.00 |
Launch Two Acquisition Units | LPBBU | Nov 22, 2024 | 9.99 | 0.00 |
Laureate Education | LAUR | Nov 22, 2024 | 19.52 | +1.30 |
LAVA Therapeutics | LVTX | Nov 22, 2024 | 1.60 | +8.11 |
Lavoro | LVRO | Nov 22, 2024 | 5.09 | +4.95 |
Lazard A | LAZ | Nov 22, 2024 | 57.70 | +1.02 |
Lazard Global Total Return and Income Fund | LGI | Nov 22, 2024 | 16.85 | +2.18 |
Lazydays | GORV | Nov 22, 2024 | 1.02 | +7.38 |
LCI Industries | LCII | Nov 22, 2024 | 120.95 | +1.34 |
LCNB | LCNB | Nov 22, 2024 | 17.27 | +2.25 |
Lead Real Estate ADR | LRE | Nov 22, 2024 | 2.20 | +1.38 |
Leafly | LFLY | Nov 22, 2024 | 1.51 | 0.00 |
Leap Therapeutics | LPTX | Nov 22, 2024 | 2.55 | -1.16 |
Lear | LEA | Nov 22, 2024 | 97.89 | +1.58 |
LeddarTech | LDTC | Nov 22, 2024 | 0.33 | +10.42 |
Lee Enterprises | LEE | Nov 22, 2024 | 16.75 | +4.04 |
Legacy Housing | LEGH | Nov 22, 2024 | 25.78 | +0.66 |
LegalZoom.com | LZ | Nov 22, 2024 | 7.83 | +0.90 |
Legato Merger III | LEGT | Nov 22, 2024 | 10.28 | -0.05 |
Legend Biotech ADR | LEGN | Nov 22, 2024 | 40.94 | +2.99 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Nov 22, 2024 | 40.82 | +0.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.